Nachrichten zur IGM Biosciences Aktie

IGM Biosciences stock surges as Biogens deal for HI-Bio is seen as a positive By Investing.com

IGM Biosciences stock surges as Biogens deal for HI-Bio is seen as a positive…

IGM Biosciences: Unlikely To Move The Needle Again In 2024

…

IGM Biosciences refines Sanofi antibody collaboration By Investing.com

IGM Biosciences refines Sanofi antibody collaboration…

IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum

MOUNTAIN VIEW, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company…

IGM Biosciences executive sells over $9,000 in stock By Investing.com

IGM Biosciences executive sells over $9,000 in stock…

IGM Biosciences CEO sells shares worth over $89k By Investing.com

IGM Biosciences CEO sells shares worth over $89k…

IGM Biosciences executive sells over $33k in company stock By Investing.com

IGM Biosciences executive sells over $33k in company stock…

IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

MOUNTAIN VIEW, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company…

IGM Biosciences: Imvotamab Data 2nd Half Of 2024 With Other Inflection Points

…

RBC Capital upgrades IGM Biosciences to outperform

…

IGM Biosciences: A New Approach To Antibodies, But Not A Value Right Now

…

IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

MOUNTAIN VIEW, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company…

Medivir’s partner IGM Biosciences announces strategic pipeline prioritization to extend its cash runway

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas…

Does IGM Biosciences, Inc. (IGMS) Have the Potential to Rally 268.31% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 268.3% in IGM Biosciences, Inc.…

IGM Biosciences Chief Commercial Officer discloses sale of 935 company shares

…

IGM Biosciences Announces Retirement of Chairman Michael Loberg, Ph.D. from Board of Directors and Appointment of Elizabeth H.Z. Thompson, Ph.D. to Board of Directors

MOUNTAIN VIEW, Calif., Oct. 03, 2023 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company…

IGM Biosciences, Inc. (IGMS) Reports Q2 Loss, Misses Revenue Estimates

IGM Biosciences, Inc. (IGMS) delivered earnings and revenue surprises of 0% and 37.43%, respectively, for the quarter ended June 2023.…

IGM Biosciences GAAP EPS of -$1.43 beats by $0.01, revenue of $0.45M misses by $0.34M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

IGM Biosciences Announces Second Quarter 2023 Financial Results

– Continued progress in clinical development across portfolio –– Public equity offering and concurrent private placement with gross proceeds of…

Insiderhandel: Aufsichtsrat verkauft Aktien von IGM Biosciences im Wert von 757.585$

Redmile Group, LLC - Aufsichtsrat - Tag der Transaktion: 2023-06-29...…

Insiderhandel: Aufsichtsrat kauft Aktien von IGM Biosciences im Wert von 32.375$

Topsoe, Jakob Haldor - Aufsichtsrat - Tag der Transaktion: 2023-06-30...…

Insiderhandel: Aufsichtsrat kauft Aktien von IGM Biosciences im Wert von 31.847$

Topsoe, Jakob Haldor - Aufsichtsrat - Tag der Transaktion: 2023-06-29...…

Insiderhandel: Aufsichtsrat kauft Aktien von IGM Biosciences im Wert von 900.000$

Behrens, M Kathleen - Aufsichtsrat - Tag der Transaktion: 2023-06-26...…

Form 8-K IGM Biosciences, Inc. For: Jun 23

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K IGM Biosciences, Inc. For: Jun 22

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Strength Seen in IGM Biosciences, Inc. (IGMS): Can Its 7.6% Jump Turn into More Strength?

IGM Biosciences, Inc. (IGMS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate…

IGM Biosciences Shares Rise 13% After Public Offering Prices

IGM Biosciences Shares Rise 13% After Public Offering Prices...…

IGM Biosciences plans for $100M stock offering and concurrent private placement

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

IGM Announces Proposed Public Offering and Concurrent Private Placement

MOUNTAIN VIEW, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (NASDAQ: IGMS) today announced that it…

Form 8-K IGM Biosciences, Inc. For: Jun 02

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development

– Additional data from Phase 1 combination with FOLFIRI continues to show encouraging activity in median third-line metastatic colorectal cancer…

IGM Biosciences to Host Conference Call and Webcast to Provide IGM-8444 Clinical Update

– Event to be webcast live on Friday, June 2, 2023 at 7:00 p.m. ET –...…

Insiderhandel: Chief Scientific Officer verkauft Aktien von IGM Biosciences im Wert von 12.087$

Keyt, Bruce - Vorstand - Tag der Transaktion: 2023-05-23...…

Insiderhandel: Chief Medical Officer verkauft Aktien von IGM Biosciences im Wert von 15.497$

Takimoto, Chris H. - Vorstand - Tag der Transaktion: 2023-05-23...…

IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Lags Revenue Estimates

IGM Biosciences, Inc. (IGMS) delivered earnings and revenue surprises of 2.92% and 70.89%, respectively, for the quarter ended March 2023.…

IGM Biosciences GAAP EPS of -$1.33 beats by $0.01, revenue of $0.52M misses by $0.79M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

IGM Biosciences Announces First Quarter 2023 Financial Results and Provides Corporate Update

– Randomized clinical trial of IGM-8444 plus FOLFIRI and bevacizumab in second line metastatic colorectal cancer underway –...…

Form 8-K IGM Biosciences, Inc. For: May 12

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 10-Q IGM Biosciences, Inc. For: Mar 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

IGM Biosciences to Present at Two Upcoming Investor Conferences

MOUNTAIN VIEW, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company…

IGM Biosciences to Present at the Stifel 2023 Targeted Oncology Days

MOUNTAIN VIEW, Calif., April 19, 2023 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company…

Insiderhandel: Chief Commercial Officer verkauft Aktien von IGM Biosciences im Wert von 11.781$

Gauthier, George - Vorstand - Tag der Transaktion: 2023-04-05...…

IGM Biosciences, Inc. (IGMS) Reports Q4 Loss, Misses Revenue Estimates

IGM Biosciences, Inc. (IGMS) delivered earnings and revenue surprises of 22.22% and 0.80%, respectively, for the quarter ended December 2022.…

IGM Biosciences GAAP EPS of -$1.19 beats by $0.01, revenue of $0.37M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

IGM Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

– Encouraging initial data from IGM-8444 combination with FOLFIRI; first patient dosed in randomized trial –...…

Earnings Preview For IGM Biosciences

IGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023

MOUNTAIN VIEW, Calif., March 27, 2023 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company…

dpa-AFX ProFeed